Aura Biosciences, Inc.
Price Action
Technical Summary
EMERGING TRENDAura Biosciences, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 69), indicating performance broadly in line with the market. Earnings growth of 9% provides fundamental context to the price action. Investors should exercise caution due to high volatility (56% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.68 | +4.72% | ABOVE |
| 50 SMA | $7.23 | -3.21% | BELOW |
| 100 SMA | $6.67 | +4.90% | ABOVE |
| 150 SMA | $6.36 | +10.02% | ABOVE |
| 200 SMA | $6.26 | +11.77% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AURA in an uptrend right now?
AURA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is AURA overbought or oversold?
AURA's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is AURA outperforming the market?
AURA has a Relative Strength (RS) Rating of 69 out of 99. AURA is performing about average compared to the market.
Where is AURA in its 52-week range?
AURA is trading at $7.00, which is 73% of its 52-week high ($9.54) and 47% above its 52-week low ($4.73).
How volatile is AURA?
AURA has a Beta of 1.53 and 52-week volatility of 56%. It's more volatile than the S&P 500 - expect bigger swings.